The global market for Non-Invasive Prenatal Testing was estimated to be worth US$ 4884.4 million in 2023 and is forecast to a readjusted size of US$ 10060 million by 2030 with a CAGR of 10.7% during the forecast period 2024-2030

Non-Invasive Prenatal Testing - Market

Non-Invasive Prenatal Testing is a method of determining the risk that the fetus will be born with certain genetic abnormalities. This testing analyzes small fragments of DNA that are circulating in a pregnant woman's blood

North American market for Non-Invasive Prenatal Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Non-Invasive Prenatal Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Non-Invasive Prenatal Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Non-Invasive Prenatal Testing include Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina and Berry Genomics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-Invasive Prenatal Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Non-Invasive Prenatal Testing by region & country, by Type, and by Application.

The Non-Invasive Prenatal Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Prenatal Testing.

Market Segmentation

Scope of Non-Invasive Prenatal Testing - Market Report

Report Metric	Details
Report Name	Non-Invasive Prenatal Testing - Market
Forecasted market size in 2030	US$ 10060 million
CAGR	10.7%
Forecasted years	2024 - 2030
Segment by Type:	High & Average Risk Low Risk
Segment by Application	0-12 Weeks 13-24 Weeks 25-36 Weeks
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina, Berry Genomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Non-Invasive Prenatal Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Non-Invasive Prenatal Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Non-Invasive Prenatal Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Non-Invasive Prenatal Testing - Market size in 2030?

Ans: The Non-Invasive Prenatal Testing - Market size in 2030 will be US$ 10060 million.

Who are the main players in the Non-Invasive Prenatal Testing - Market report?

Ans: The main players in the Non-Invasive Prenatal Testing - Market are Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina, Berry Genomics

What are the Application segmentation covered in the Non-Invasive Prenatal Testing - Market report?

Ans: The Applications covered in the Non-Invasive Prenatal Testing - Market report are 0-12 Weeks, 13-24 Weeks, 25-36 Weeks

What are the Type segmentation covered in the Non-Invasive Prenatal Testing - Market report?

Ans: The Types covered in the Non-Invasive Prenatal Testing - Market report are High & Average Risk, Low Risk

1 Market Overview

1.1 Non-Invasive Prenatal Testing Product Introduction

1.2 Global Non-Invasive Prenatal Testing Market Size Forecast

1.3 Non-Invasive Prenatal Testing Market Trends & Drivers

1.3.1 Non-Invasive Prenatal Testing Industry Trends

1.3.2 Non-Invasive Prenatal Testing Market Drivers & Opportunity

1.3.3 Non-Invasive Prenatal Testing Market Challenges

1.3.4 Non-Invasive Prenatal Testing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Non-Invasive Prenatal Testing Players Revenue Ranking (2023)

2.2 Global Non-Invasive Prenatal Testing Revenue by Company (2019-2024)

2.3 Key Companies Non-Invasive Prenatal Testing Manufacturing Base Distribution and Headquarters

2.4 Key Companies Non-Invasive Prenatal Testing Product Offered

2.5 Key Companies Time to Begin Mass Production of Non-Invasive Prenatal Testing

2.6 Non-Invasive Prenatal Testing Market Competitive Analysis

2.6.1 Non-Invasive Prenatal Testing Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Non-Invasive Prenatal Testing Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 High & Average Risk

3.1.2 Low Risk

3.2 Global Non-Invasive Prenatal Testing Sales Value by Type

3.2.1 Global Non-Invasive Prenatal Testing Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Non-Invasive Prenatal Testing Sales Value, by Type (2019-2030)

3.2.3 Global Non-Invasive Prenatal Testing Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 0-12 Weeks

4.1.2 13-24 Weeks

4.1.3 25-36 Weeks

4.2 Global Non-Invasive Prenatal Testing Sales Value by Application

4.2.1 Global Non-Invasive Prenatal Testing Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Non-Invasive Prenatal Testing Sales Value, by Application (2019-2030)

4.2.3 Global Non-Invasive Prenatal Testing Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Non-Invasive Prenatal Testing Sales Value by Region

5.1.1 Global Non-Invasive Prenatal Testing Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Non-Invasive Prenatal Testing Sales Value by Region (2019-2024)

5.1.3 Global Non-Invasive Prenatal Testing Sales Value by Region (2025-2030)

5.1.4 Global Non-Invasive Prenatal Testing Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Non-Invasive Prenatal Testing Sales Value, 2019-2030

5.2.2 North America Non-Invasive Prenatal Testing Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Non-Invasive Prenatal Testing Sales Value, 2019-2030

5.3.2 Europe Non-Invasive Prenatal Testing Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Non-Invasive Prenatal Testing Sales Value, 2019-2030

5.4.2 Asia Pacific Non-Invasive Prenatal Testing Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Non-Invasive Prenatal Testing Sales Value, 2019-2030

5.5.2 South America Non-Invasive Prenatal Testing Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Non-Invasive Prenatal Testing Sales Value, 2019-2030

5.6.2 Middle East & Africa Non-Invasive Prenatal Testing Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Non-Invasive Prenatal Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Non-Invasive Prenatal Testing Sales Value

6.3 United States

6.3.1 United States Non-Invasive Prenatal Testing Sales Value, 2019-2030

6.3.2 United States Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Non-Invasive Prenatal Testing Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Non-Invasive Prenatal Testing Sales Value, 2019-2030

6.4.2 Europe Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Non-Invasive Prenatal Testing Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Non-Invasive Prenatal Testing Sales Value, 2019-2030

6.5.2 China Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

6.5.3 China Non-Invasive Prenatal Testing Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Non-Invasive Prenatal Testing Sales Value, 2019-2030

6.6.2 Japan Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Non-Invasive Prenatal Testing Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Non-Invasive Prenatal Testing Sales Value, 2019-2030

6.7.2 South Korea Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Non-Invasive Prenatal Testing Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Non-Invasive Prenatal Testing Sales Value, 2019-2030

6.8.2 Southeast Asia Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Non-Invasive Prenatal Testing Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Non-Invasive Prenatal Testing Sales Value, 2019-2030

6.9.2 India Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

6.9.3 India Non-Invasive Prenatal Testing Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sequenom

7.1.1 Sequenom Profile

7.1.2 Sequenom Main Business

7.1.3 Sequenom Non-Invasive Prenatal Testing Products, Services and Solutions

7.1.4 Sequenom Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2024)

7.1.5 Sequenom Recent Developments

7.2 Roche

7.2.1 Roche Profile

7.2.2 Roche Main Business

7.2.3 Roche Non-Invasive Prenatal Testing Products, Services and Solutions

7.2.4 Roche Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2024)

7.2.5 Roche Recent Developments

7.3 Natera

7.3.1 Natera Profile

7.3.2 Natera Main Business

7.3.3 Natera Non-Invasive Prenatal Testing Products, Services and Solutions

7.3.4 Natera Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2024)

7.3.5 LabCorp Recent Developments

7.4 LabCorp

7.4.1 LabCorp Profile

7.4.2 LabCorp Main Business

7.4.3 LabCorp Non-Invasive Prenatal Testing Products, Services and Solutions

7.4.4 LabCorp Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2024)

7.4.5 LabCorp Recent Developments

7.5 BGI Genomics

7.5.1 BGI Genomics Profile

7.5.2 BGI Genomics Main Business

7.5.3 BGI Genomics Non-Invasive Prenatal Testing Products, Services and Solutions

7.5.4 BGI Genomics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2024)

7.5.5 BGI Genomics Recent Developments

7.6 Quest Diagnostics

7.6.1 Quest Diagnostics Profile

7.6.2 Quest Diagnostics Main Business

7.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Products, Services and Solutions

7.6.4 Quest Diagnostics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2024)

7.6.5 Quest Diagnostics Recent Developments

7.7 Illumina

7.7.1 Illumina Profile

7.7.2 Illumina Main Business

7.7.3 Illumina Non-Invasive Prenatal Testing Products, Services and Solutions

7.7.4 Illumina Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2024)

7.7.5 Illumina Recent Developments

7.8 Berry Genomics

7.8.1 Berry Genomics Profile

7.8.2 Berry Genomics Main Business

7.8.3 Berry Genomics Non-Invasive Prenatal Testing Products, Services and Solutions

7.8.4 Berry Genomics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2024)

7.8.5 Berry Genomics Recent Developments

8 Industry Chain Analysis

8.1 Non-Invasive Prenatal Testing Industrial Chain

8.2 Non-Invasive Prenatal Testing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Non-Invasive Prenatal Testing Sales Model

8.5.2 Sales Channel

8.5.3 Non-Invasive Prenatal Testing Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Non-Invasive Prenatal Testing Market Trends

Table 2. Non-Invasive Prenatal Testing Market Drivers & Opportunity

Table 3. Non-Invasive Prenatal Testing Market Challenges

Table 4. Non-Invasive Prenatal Testing Market Restraints

Table 5. Global Non-Invasive Prenatal Testing Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Non-Invasive Prenatal Testing Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Non-Invasive Prenatal Testing Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Non-Invasive Prenatal Testing Product Type

Table 9. Key Companies Time to Begin Mass Production of Non-Invasive Prenatal Testing

Table 10. Global Non-Invasive Prenatal Testing Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Non-Invasive Prenatal Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Non-Invasive Prenatal Testing Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Non-Invasive Prenatal Testing Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Non-Invasive Prenatal Testing Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Non-Invasive Prenatal Testing Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Non-Invasive Prenatal Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Non-Invasive Prenatal Testing Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Non-Invasive Prenatal Testing Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Non-Invasive Prenatal Testing Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Non-Invasive Prenatal Testing Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Non-Invasive Prenatal Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Non-Invasive Prenatal Testing Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Non-Invasive Prenatal Testing Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Non-Invasive Prenatal Testing Sales Value by Region (2019-2024) & (%)

Table 27. Global Non-Invasive Prenatal Testing Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Non-Invasive Prenatal Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Non-Invasive Prenatal Testing Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Non-Invasive Prenatal Testing Sales Value, (2025-2030) & (US$ Million)

Table 31. Sequenom Basic Information List

Table 32. Sequenom Description and Business Overview

Table 33. Sequenom Non-Invasive Prenatal Testing Products, Services and Solutions

Table 34. Revenue (US$ Million) in Non-Invasive Prenatal Testing Business of Sequenom (2019-2024)

Table 35. Sequenom Recent Developments

Table 36. Roche Basic Information List

Table 37. Roche Description and Business Overview

Table 38. Roche Non-Invasive Prenatal Testing Products, Services and Solutions

Table 39. Revenue (US$ Million) in Non-Invasive Prenatal Testing Business of Roche (2019-2024)

Table 40. Roche Recent Developments

Table 41. Natera Basic Information List

Table 42. Natera Description and Business Overview

Table 43. Natera Non-Invasive Prenatal Testing Products, Services and Solutions

Table 44. Revenue (US$ Million) in Non-Invasive Prenatal Testing Business of Natera (2019-2024)

Table 45. Natera Recent Developments

Table 46. LabCorp Basic Information List

Table 47. LabCorp Description and Business Overview

Table 48. LabCorp Non-Invasive Prenatal Testing Products, Services and Solutions

Table 49. Revenue (US$ Million) in Non-Invasive Prenatal Testing Business of LabCorp (2019-2024)

Table 50. LabCorp Recent Developments

Table 51. BGI Genomics Basic Information List

Table 52. BGI Genomics Description and Business Overview

Table 53. BGI Genomics Non-Invasive Prenatal Testing Products, Services and Solutions

Table 54. Revenue (US$ Million) in Non-Invasive Prenatal Testing Business of BGI Genomics (2019-2024)

Table 55. BGI Genomics Recent Developments

Table 56. Quest Diagnostics Basic Information List

Table 57. Quest Diagnostics Description and Business Overview

Table 58. Quest Diagnostics Non-Invasive Prenatal Testing Products, Services and Solutions

Table 59. Revenue (US$ Million) in Non-Invasive Prenatal Testing Business of Quest Diagnostics (2019-2024)

Table 60. Quest Diagnostics Recent Developments

Table 61. Illumina Basic Information List

Table 62. Illumina Description and Business Overview

Table 63. Illumina Non-Invasive Prenatal Testing Products, Services and Solutions

Table 64. Revenue (US$ Million) in Non-Invasive Prenatal Testing Business of Illumina (2019-2024)

Table 65. Illumina Recent Developments

Table 66. Berry Genomics Basic Information List

Table 67. Berry Genomics Description and Business Overview

Table 68. Berry Genomics Non-Invasive Prenatal Testing Products, Services and Solutions

Table 69. Revenue (US$ Million) in Non-Invasive Prenatal Testing Business of Berry Genomics (2019-2024)

Table 70. Berry Genomics Recent Developments

Table 71. Key Raw Materials Lists

Table 72. Raw Materials Key Suppliers Lists

Table 73. Non-Invasive Prenatal Testing Downstream Customers

Table 74. Non-Invasive Prenatal Testing Distributors List

Table 75. Research Programs/Design for This Report

Table 76. Key Data Information from Secondary Sources

Table 77. Key Data Information from Primary Sources

Table 78. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Non-Invasive Prenatal Testing Product Picture

Figure 2. Global Non-Invasive Prenatal Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Non-Invasive Prenatal Testing Sales Value (2019-2030) & (US$ Million)

Figure 4. Non-Invasive Prenatal Testing Report Years Considered

Figure 5. Global Non-Invasive Prenatal Testing Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-Invasive Prenatal Testing Revenue in 2023

Figure 7. Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. High & Average Risk Picture

Figure 9. Low Risk Picture

Figure 10. Global Non-Invasive Prenatal Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Non-Invasive Prenatal Testing Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of 0-12 Weeks

Figure 13. Product Picture of 13-24 Weeks

Figure 14. Product Picture of 25-36 Weeks

Figure 15. Global Non-Invasive Prenatal Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Non-Invasive Prenatal Testing Sales Value Market Share by Application, 2023 & 2030

Figure 17. North America Non-Invasive Prenatal Testing Sales Value (2019-2030) & (US$ Million)

Figure 18. North America Non-Invasive Prenatal Testing Sales Value by Country (%), 2023 VS 2030

Figure 19. Europe Non-Invasive Prenatal Testing Sales Value (2019-2030) & (US$ Million)

Figure 20. Europe Non-Invasive Prenatal Testing Sales Value by Country (%), 2023 VS 2030

Figure 21. Asia Pacific Non-Invasive Prenatal Testing Sales Value (2019-2030) & (US$ Million)

Figure 22. Asia Pacific Non-Invasive Prenatal Testing Sales Value by Country (%), 2023 VS 2030

Figure 23. South America Non-Invasive Prenatal Testing Sales Value (2019-2030) & (US$ Million)

Figure 24. South America Non-Invasive Prenatal Testing Sales Value by Country (%), 2023 VS 2030

Figure 25. Middle East & Africa Non-Invasive Prenatal Testing Sales Value (2019-2030) & (US$ Million)

Figure 26. Middle East & Africa Non-Invasive Prenatal Testing Sales Value by Country (%), 2023 VS 2030

Figure 27. Key Countries/Regions Non-Invasive Prenatal Testing Sales Value (%), (2019-2030)

Figure 28. United States Non-Invasive Prenatal Testing Sales Value, (2019-2030) & (US$ Million)

Figure 29. United States Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

Figure 30. United States Non-Invasive Prenatal Testing Sales Value by Application (%), 2023 VS 2030

Figure 31. Europe Non-Invasive Prenatal Testing Sales Value, (2019-2030) & (US$ Million)

Figure 32. Europe Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

Figure 33. Europe Non-Invasive Prenatal Testing Sales Value by Application (%), 2023 VS 2030

Figure 34. China Non-Invasive Prenatal Testing Sales Value, (2019-2030) & (US$ Million)

Figure 35. China Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

Figure 36. China Non-Invasive Prenatal Testing Sales Value by Application (%), 2023 VS 2030

Figure 37. Japan Non-Invasive Prenatal Testing Sales Value, (2019-2030) & (US$ Million)

Figure 38. Japan Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

Figure 39. Japan Non-Invasive Prenatal Testing Sales Value by Application (%), 2023 VS 2030

Figure 40. South Korea Non-Invasive Prenatal Testing Sales Value, (2019-2030) & (US$ Million)

Figure 41. South Korea Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

Figure 42. South Korea Non-Invasive Prenatal Testing Sales Value by Application (%), 2023 VS 2030

Figure 43. Southeast Asia Non-Invasive Prenatal Testing Sales Value, (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

Figure 45. Southeast Asia Non-Invasive Prenatal Testing Sales Value by Application (%), 2023 VS 2030

Figure 46. India Non-Invasive Prenatal Testing Sales Value, (2019-2030) & (US$ Million)

Figure 47. India Non-Invasive Prenatal Testing Sales Value by Type (%), 2023 VS 2030

Figure 48. India Non-Invasive Prenatal Testing Sales Value by Application (%), 2023 VS 2030

Figure 49. Non-Invasive Prenatal Testing Industrial Chain

Figure 50. Non-Invasive Prenatal Testing Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions